AAV Capsid Analysis With Mass Photometry

The demand for gene therapies utilizing adeno-associated virus (AAV) vectors is on the rise, along with the critical role of comprehensive analytical methods for quality AAV production. Mass photometry provides speed and accuracy in AAV processing and the ability to measure AAVs regardless of serotype. ABL, a CDMO providing end-to-end viral vector manufacturing services, delves into how mass photometry can accelerate initial process development, enhance the polishing stage, and swiftly identify critical quality attributes of AAV samples. The webinar will also shed light on the wider applications of mass photometry and tailored software solutions for GMP-regulated environments.